0001437749-17-016704.txt : 20171003 0001437749-17-016704.hdr.sgml : 20171003 20171003163759 ACCESSION NUMBER: 0001437749-17-016704 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171002 FILED AS OF DATE: 20171003 DATE AS OF CHANGE: 20171003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hamel Lawrence G CENTRAL INDEX KEY: 0001511368 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35068 FILM NUMBER: 171118472 MAIL ADDRESS: STREET 1: C/O ACELRX PHARMACEUTICALS INC. STREET 2: 575 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACELRX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001427925 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 351 GALVESTON DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-216-3500 MAIL ADDRESS: STREET 1: 351 GALVESTON DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 rdgdoc.xml HAMEL - 10/2/17 FORM 4 X0306 4 2017-10-02 0001427925 ACELRX PHARMACEUTICALS INC ACRX 0001511368 Hamel Lawrence G C/O ACELRX PHARMACEUTICALS, INC. 351 GALVESTON DRIVE REDWOOD CITY CA 94063 1 Chief Development Officer Common Stock 2017-10-02 4 S 0 10161 5.29 D 41964 I See footnote Common Stock 16379 D Shares sold pursuant to a 10b5-1 plan. The Shares were sold at prices ranging from $5.10 to $5.50. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The Shares are held in the Hamel Revocable Living Trust. /s/ Martha Adler, as attorney-in-fact 2017-10-03